Good publishing practice

European Heart Journal

Volumn 33, Issue 5, 2012, Pages 557-561

  Lscher, Thomas F ^a  

^a University Hospital of Zurich   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; PUBLICATION; REVIEW;

CARDIOLOGY; CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; EDUCATION, MEDICAL, CONTINUING; HEALTH CARE SECTOR; INTERPROFESSIONAL RELATIONS; ORGANIZATIONAL POLICY; PERIODICALS AS TOPIC; SOCIETIES, MEDICAL;

EID: 84857947574     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr506     Document Type: Review

References (30)

1. Krimsky S. Science in the Private Interest. Lanham, MD: Bowman & Littlefield Publishers, Inc., 2003. 28-33.
2. Lüscher T, Gedankenmedizin F. In: 'Conflict of Interest' oder Interesse am Konflikt? Heidelberg: Springer, 2010. 123-136.
3. Hill AB. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ 1948; 769-773.
4. Avorn J. Learning about safety of drugs. N Engl J Med 2011;365:2151-2153.
5. Lenz W. Deformities in children after prescribed drug use during pregnancy? Dtsch Med Wochenschr 1961;86:2555-2555.
6. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961;2: 1358-1358.
7. Barnhart CL (ed.) The American College Dictionary. New York: Random House.
8. Oldenburg H. The Correspondence of Henry Oldenburg. Edited and translated by Hall AR, Hall MB. 13 Volumes. University of Wisconsin Press, 1965-1986.
9. Speech held in the House of Commons on November 11, 1947.
10. Goldstone L, Goldstone N. Out of Flames. New York: Broadway Books, 2002.
11. ForssmannW. Experiments on Myself. Memoirs of a Surgeon in Germany. New York: Saint Martins Press, 1974.
12. Kuhn TS. The Structure of Scientific Revolutions. 3rd ed. Chicago: The University of Chicago Press Books, 1996.
13. ESC Board. Relations between professional medical associations and the healthcare industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology. Eur Heart J 2012;33:666-674.
14. Alfonso F, Timmis A, Pinto FJ, Ambrosio G, Ector H, Kulakowski P, Vardas P, on behalf of the Editors' Network European Society of Cardiology Task Force. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals. Eur Heart J 2012;33: 587-594.
15. O'Neill O. A Question of Trust. BBC Reith Lectures 2002. Cambridge: Cambridge University Press, 2010.
16. Krimsky S. Science in the Private Interest. Lanham, MD: Bowman & Littlefield Publishers, Inc., 2003. p142.
17. Popper K. Conjectures and Refutations. The Growth of Scientific Knowledge. London: Routledge and Kegan Paul, 1974.
18. Wakefield AI, Murch SH, Anthon A, Linnel J, Casson DM, Malik M. Ileal lymphoid nodule hyperplasia, non-specific colitis and pervasive development disorders in children. Lancet 1998;351:637-641.
19. Lüscher TF, Landmesser U, Ruschitzka F. Standing firm-the European Heart Journal, scientific discoveries and the industry. Eur Heart J 2010;31:1157-1158.
20. Furberg CD, Psaty BM, Meyer VJ. Nifedipine: dose-related increase in mortality in patients with coronary artery disease. Circulation 1995;92:1326-1331.
21. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:779-785.
22. The ALLHAT officers and coordinators for the ALLHAT Collaboration Research Group: major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002;288:2981-2997.
23. Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S; Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004;364:849-857. (Pubitemid 39221062)
24. Godlee F. Institutional research misconduct. BMJ 2011;343:971.
25. Wise J. Extent of Dutch psychologist's trial fraud was unprecedented. BMJ 2011; 343: 969 or www.tilburguniversity.edu/nl/nieuwsen-agenda/commissie- levelt/interim-report.pdf
26. www.theheart.org/article/1315171.do
27. Winnik SH, Raptis DA, Walker JH, Hasun M, Speer T, Clavien P-A, Komajda M, Bax JJ, Tandera M, Fox K, Van De Werf F, Mundow C, Lüscher TF, Ruschitzka F, Matter CM. From abstract to impact in cardiovascular research: factors predicting scientific quality, Eur Heart J 2012;in press.
28. Maddox B. Rosalind Franklin: The Dark Lady of DNA. Harper Collins, 2002.
29. Watson J, Crick F. Molecular structure of nucleic acid: a structure for desoxyribose nucleic acid. Nature 1953;171:737-734.
30. De Angelis CD, Draze JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJPM, Schroeder TV, Sox HC, Van Der Weyden MB. Is this clinical trial fully registered? A Statement from the International Committee of Medical Journal Editors. N Engl J Med 2005;352: 2436-2438. (Pubitemid 40958442)